000910205 001__ 910205
000910205 005__ 20230123110659.0
000910205 0247_ $$2doi$$a10.1093/neuonc/noac120
000910205 0247_ $$2ISSN$$a1522-8517
000910205 0247_ $$2ISSN$$a1523-5866
000910205 0247_ $$2Handle$$a2128/32783
000910205 0247_ $$2pmid$$a35512714
000910205 0247_ $$2WOS$$aWOS:000803278300001
000910205 037__ $$aFZJ-2022-03682
000910205 082__ $$a610
000910205 1001_ $$0P:(DE-Juel1)143792$$aGalldiks, Norbert$$b0$$eCorresponding author
000910205 245__ $$aThe role of 11C-methionine PET in patients with newly diagnosed WHO grade 2 or 3 gliomas
000910205 260__ $$aOxford$$bOxford Univ. Press$$c2022
000910205 3367_ $$2DRIVER$$aarticle
000910205 3367_ $$2DataCite$$aOutput Types/Journal article
000910205 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1669292144_5009
000910205 3367_ $$2BibTeX$$aARTICLE
000910205 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000910205 3367_ $$00$$2EndNote$$aJournal Article
000910205 536__ $$0G:(DE-HGF)POF4-5253$$a5253 - Neuroimaging (POF4-525)$$cPOF4-525$$fPOF IV$$x0
000910205 588__ $$aDataset connected to CrossRef, Journals: juser.fz-juelich.de
000910205 7001_ $$0P:(DE-Juel1)145110$$aLohmann, Philipp$$b1
000910205 7001_ $$0P:(DE-Juel1)131777$$aLangen, Karl-Josef$$b2$$ufzj
000910205 773__ $$0PERI:(DE-600)2094060-9$$a10.1093/neuonc/noac120$$gVol. 24, no. 9, p. 1557 - 1558$$n9$$p1557 - 1558$$tNeuro-Oncology$$v24$$x1522-8517$$y2022
000910205 8564_ $$uhttps://juser.fz-juelich.de/record/910205/files/Galldiks2022NeuroOnc.pdf$$yPublished on 2022-09-09. Available in OpenAccess from 2023-09-09.
000910205 909CO $$ooai:juser.fz-juelich.de:910205$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
000910205 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)143792$$aForschungszentrum Jülich$$b0$$kFZJ
000910205 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)145110$$aForschungszentrum Jülich$$b1$$kFZJ
000910205 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131777$$aForschungszentrum Jülich$$b2$$kFZJ
000910205 9131_ $$0G:(DE-HGF)POF4-525$$1G:(DE-HGF)POF4-520$$2G:(DE-HGF)POF4-500$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$9G:(DE-HGF)POF4-5253$$aDE-HGF$$bKey Technologies$$lNatural, Artificial and Cognitive Information Processing$$vDecoding Brain Organization and Dysfunction$$x0
000910205 9141_ $$y2022
000910205 915__ $$0StatID:(DE-HGF)0530$$2StatID$$aEmbargoed OpenAccess
000910205 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-02-03
000910205 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-02-03
000910205 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2022-11-08$$wger
000910205 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2022-11-08
000910205 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2022-11-08
000910205 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2022-11-08
000910205 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2022-11-08
000910205 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bNEURO-ONCOLOGY : 2021$$d2022-11-08
000910205 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2022-11-08
000910205 915__ $$0StatID:(DE-HGF)9910$$2StatID$$aIF >= 10$$bNEURO-ONCOLOGY : 2021$$d2022-11-08
000910205 9201_ $$0I:(DE-Juel1)INM-4-20090406$$kINM-4$$lPhysik der Medizinischen Bildgebung$$x0
000910205 9201_ $$0I:(DE-Juel1)INM-3-20090406$$kINM-3$$lKognitive Neurowissenschaften$$x1
000910205 9801_ $$aFullTexts
000910205 980__ $$ajournal
000910205 980__ $$aVDB
000910205 980__ $$aUNRESTRICTED
000910205 980__ $$aI:(DE-Juel1)INM-4-20090406
000910205 980__ $$aI:(DE-Juel1)INM-3-20090406